+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • December 2024
  • 194 Pages
  • Global
From
Alpha-1 Antitrypsin Drugs - Global Strategic Business Report - Product Thumbnail Image

Alpha-1 Antitrypsin Drugs - Global Strategic Business Report

  • Report
  • December 2024
  • 193 Pages
  • Global
From
Bronchodilators - Global Strategic Business Report - Product Thumbnail Image

Bronchodilators - Global Strategic Business Report

  • Report
  • December 2024
  • 93 Pages
  • Global
From
Pneumonia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • December 2024
  • 100 Pages
  • Global
From
Epinephrine Autoinjectors - Global Strategic Business Report - Product Thumbnail Image

Epinephrine Autoinjectors - Global Strategic Business Report

  • Report
  • December 2024
  • 193 Pages
  • Global
From
Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report

  • Report
  • December 2024
  • 194 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment - Global Strategic Business Report - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment - Global Strategic Business Report

  • Report
  • December 2024
  • 299 Pages
  • Global
From
Tuberculosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tuberculosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2024
  • 283 Pages
  • Global
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2024
  • 282 Pages
  • Global
From
Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration, Treatment Mode, Region, By Country: 2020-2030 - Product Thumbnail Image

Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration, Treatment Mode, Region, By Country: 2020-2030

  • Report
  • August 2024
  • 333 Pages
  • Global
From
Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast - Product Thumbnail Image

Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

  • Report
  • January 2024
  • 250 Pages
  • Global
From
Healthcare-associated Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034? - Product Thumbnail Image

Healthcare-associated Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Lung Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Lung Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2024-2032 - Product Thumbnail Image

Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2024-2032

  • Report
  • April 2024
  • 136 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis, 2024-2032 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis, 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Global Strategic Business Report - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

  • Report
  • December 2024
  • 181 Pages
  • Global
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • December 2024
  • 93 Pages
  • Global
From
Montelukast API Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Montelukast API Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • July 2024
  • Global
From
Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • July 2024
  • Global
From
Bronchodilator Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Bronchodilator Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more